Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection

PHASE4RecruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

July 28, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

ET

Empirical therapy Based on drug history: Levofloxacin sequential therapy or bismuth quadruple therapy (10 or 14 days) or rifabutin triple/quadruple therapy or concomitant therapy

DRUG

SGT

Susceptibility testing guided therapy Based on susceptibility test: Levofloxacin sequential therapy or bismuth quadruple therapy (10 or 14 days) or rifabutin triple/quadruple therapy or concomitant therapy

Trial Locations (1)

10002

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER